MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Investments$91,312K (-19.08%↓ Y/Y)Cash and cashequivalents$19,194K (-36.01%↓ Y/Y)Prepaid expenses andother current assets$4,888K (25.43%↑ Y/Y)Total current assets$115,394K (-21.35%↓ Y/Y)Right-of-use assets$8,207K (-53.00%↓ Y/Y)Restricted cash$833K (1.09%↑ Y/Y)Property and equipment,net$310K (-74.46%↓ Y/Y)Other non-currentassets$285K (77.02%↑ Y/Y)Total assets$125,029K (-24.86%↓ Y/Y)Total liabilities andstockholders' equity$125,029K (-24.86%↓ Y/Y)Total stockholders'equity$96,091K (-27.54%↓ Y/Y)Total liabilities$28,938K (-14.32%↓ Y/Y)Accumulated deficit-$483,681K (-9.65%↓ Y/Y)Accumulated othercomprehensive (loss) income-$68K (-172.00%↓ Y/Y)Additional paid-in capital$579,832K (1.06%↑ Y/Y)Total currentliabilities$15,843K (-5.72%↓ Y/Y)Non-current operating leaseliabilities$13,095K (-22.83%↓ Y/Y)Common stock 0.0001 parvalue 500,000,000...$8K (14.29%↑ Y/Y)Accrued expenses andother current...$14,439K (-9.95%↓ Y/Y)Accounts payable$1,404K (82.10%↑ Y/Y)
Balance Sheet

Black Diamond Therapeutics, Inc. (BDTX)

Black Diamond Therapeutics, Inc. (BDTX)

source: myfinsight.com